Skip to main content
VIROLOGIC OUTCOMES OF LAMIVUDINE/DOLUTEGRAVIR IN VIROLOGICALLY SUPPRESSED SUBJECTS WITH EXPECTED OR CONFIRMED RESISTANCE TO LAMIVUDINE
- ACRONYM: VOLVER
- FSG CODE: GESIDA 11820
- COORDINATOR: JOSÉ RAMÓN ARRIBAS LÓPEZ / FEDERICO PULIDO
- COORDINATOR’S HOSPITAL: HOSPITAL UNIVERSITARIO LA PAZ, MADRID / HOSPITAL UNIVERSITARIO 12 DE OCTUBRE, MADRID
- APPROVAL DATE: 22-JUL.-2020
- PROTOCOL STATUS: ANALYZING DATA / PUBLISHED
- CEIC-S APPROVAL: YES
- AEMYPS APPROVAL: YES
- ENROLED PATIENTS: 121
- TOTAL NUMBER OF PATIENTS TO INCLUDE: 120
- SCIENTIFIC OUTPUT: PUBLISHED